Drugs in Dev. Hepatology (Liver, Pancreatic, Gall Bladder)
Undisclosed
China 
Lead Product(s) : ASC41,Aramchol meglumine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Undisclosed
Sponsor : Galmed Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Details : ASC41 is an oral thyroid hormone receptor beta agonist and Aramchol is a novel synthetic small molecule, a conjugate of cholic acid and arachidic acid, linked by a stable amide group. The team will work together combining both the therapies for the treat...
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
October 09, 2020
Lead Product(s) : ASC41,Aramchol meglumine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Undisclosed
Sponsor : Galmed Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Lead Product(s) : Vitamin E
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Undisclosed
Sponsor : R&G PharmaStudies Co | The Affiliated Hospital of Hangzhou Normal University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
November 11, 2016
Lead Product(s) : Vitamin E
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Undisclosed
Sponsor : R&G PharmaStudies Co | The Affiliated Hospital of Hangzhou Normal University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
